Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Combining Blood Pressure Drugs May Increase Kidney Damage Risk November 19, 2013 Martha Garcia Add Your Comments New research suggests that it may not be beneficial to combine certain blood pressure medications, in fact, it may be quite dangerous, to mix medications like losartan and lisinopril. In a study published last week by the New England Journal of Medicine (NEJM), researchers found that combining angiotensin-converting-enzyme (ACE) inhibitors and an angiotensin-receptor blockers (ARB) does not help reduce end-stage kidney disease and actually causes more harm to the kidneys. As result, doctors have been warned against combining the blood pressure drugs. The research was conducted between 2008 and 2012, offering nearly 1,500 participants with diabetes 100 mg per day or losortan. Researchers then randomly assigned participants to groups receiving either 10 to 40 mg per day or lisinopril or a placebo. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION After concerns surfaced about an increase in safety events among individuals taking both blood pressure medications, the study was stopped early. The monotherapy group experienced 152 events and the combination-therapy group experienced 132 events, leading researchers to concluded that the combination therapy provided no added benefit for taking both drugs. ACE inhibitors and ARBs, like losartan and lisinopril, are blood pressure medications which are prescribed to help with kidney disease triggered by diabetes. They help lower blood pressure and reduce the amount of protein in the urine, often a sign of kidney damage. All participants had significant kidney disease, but not end-stage kidney disease, a condition which causes the kidneys to stop functioning at a level needed for daily life. The most common causes of end-stage kidney disease are diabetes and high blood pressure, but typically effects occur slowly over a 10 to 20 year period. Researchers thought by combining the two medications, the progression of end-stage kidney disease would be slowed dramatically. While some patients saw a slight decrease in the progression of the disease, the change was not significant. Instead, a significant increase in serious side effects was seen. More study participants required hospitalizations, additional kidney treatments and symptoms of severe kidney injury. The combination group also faced an increased the risk of hyperkalemia, elevated levels of potassium in the blood. At extremely high levels, hyperkalemia can cause cardiac arrest and death. No difference was seen in the death rates between the two groups or any improvement in heart related events. The combination therapy lead to more than double the risk of hyperkalemia and nearly twice the risk of severe kidney injury. Researchers concluded that the worse a participants kidney disease had progressed, the more likely combination therapy was to cause problems and speed the progression of end-stage kidney disease. The findings suggest that the body seems to have a threshold for how much angiotensin can be blocked. Once that level has been reached, more harm to the body occurs than benefit. Study authors concluded it is not safe to use both an ACE inhibitor and ARBs in combination. They recommend patients taking both speak with their doctor, the risk to benefit ratio does not support using both. Image Credit: | More Lawsuit Stories Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims July 24, 2025 Oxbryta Wrongful Death Lawsuit Set for Trial in Sept. 2027 July 24, 2025 Nursing Home Malnutrition Problems Raise Concerns Among Regulators, Consumer Advocates July 24, 2025 1 Comments betty June 16, 2019 my husband Raymond Thomas died feb 27 2019 he had been sick 4 years he had diabetes CHF COPD Kidney Failure he has been taking a lot different drugs Lisinopril and heart medications I wonder if you could pull his medical files and see if any of his medication took away some years we would have had Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims (Posted: today) A federal judge has issued a census order to gain an accurate count of all Similac NEC lawsuits filed against Abbott Laboratories. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court (07/08/2025)NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 (06/23/2025)Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (06/17/2025) Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (Posted: yesterday) The first BioZorb lawsuit set to go before a jury in early September will involve claims that a woman had to undergo an unplanned mastectomy due to complications. MORE ABOUT: BIOZORB LAWSUITLawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025) Thousands of Unfiled AFFF Lawsuits May Disrupt MDL Schedule, Ongoing Settlement Talks (Posted: 2 days ago) A federal judge is calling on lawyers for plaintiffs and defendants to address concerns about thousands of potentially unfiled AFFF lawsuits, which could affect settlement negotiations. MORE ABOUT: AFFF LAWSUITHouse Bill Would Extend Military Use of PFAS Firefighter Foam for 3 Years (07/17/2025)$27 Million PFAS Water Contamination Settlement Reached By DuPont in New York Lawsuit (07/14/2025)Cancer-Causing PFAS Water Contamination in 98% of Tested Sites in U.S.: Report (07/11/2025)
Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims (Posted: today) A federal judge has issued a census order to gain an accurate count of all Similac NEC lawsuits filed against Abbott Laboratories. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court (07/08/2025)NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 (06/23/2025)Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (06/17/2025)
Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (Posted: yesterday) The first BioZorb lawsuit set to go before a jury in early September will involve claims that a woman had to undergo an unplanned mastectomy due to complications. MORE ABOUT: BIOZORB LAWSUITLawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)
Thousands of Unfiled AFFF Lawsuits May Disrupt MDL Schedule, Ongoing Settlement Talks (Posted: 2 days ago) A federal judge is calling on lawyers for plaintiffs and defendants to address concerns about thousands of potentially unfiled AFFF lawsuits, which could affect settlement negotiations. MORE ABOUT: AFFF LAWSUITHouse Bill Would Extend Military Use of PFAS Firefighter Foam for 3 Years (07/17/2025)$27 Million PFAS Water Contamination Settlement Reached By DuPont in New York Lawsuit (07/14/2025)Cancer-Causing PFAS Water Contamination in 98% of Tested Sites in U.S.: Report (07/11/2025)